Kelly M. Brady
Chief Tech/Sci/R&D Officer chez SERES THERAPEUTICS, INC.
Profil
Kelly M.
Brady is currently the Vice President-Clinical Operations at Seres Therapeutics, Inc. She previously worked as a Senior Director at Akebia Therapeutics, Inc. and as a Member-Operations Team at Osiris Therapeutics, Inc. Ms. Brady holds a graduate degree from The Johns Hopkins University and an undergraduate degree from Lafayette College.
Postes actifs de Kelly M. Brady
| Sociétés | Poste | Début |
|---|---|---|
| SERES THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2018 |
Anciens postes connus de Kelly M. Brady
| Sociétés | Poste | Fin |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Kelly M. Brady
| The Johns Hopkins University | Graduate Degree |
| Lafayette College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| SERES THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
